nodes	percent_of_prediction	percent_of_DWPC	metapath
Clobetasol propionate—CYP1A1—Tretinoin—peripheral nervous system neoplasm	0.223	0.343	CbGbCtD
Clobetasol propionate—CYP1A1—Dacarbazine—peripheral nervous system neoplasm	0.192	0.295	CbGbCtD
Clobetasol propionate—CYP1A2—Alitretinoin—peripheral nervous system neoplasm	0.107	0.165	CbGbCtD
Clobetasol propionate—CYP1A2—Dacarbazine—peripheral nervous system neoplasm	0.0858	0.132	CbGbCtD
Clobetasol propionate—CYP1A2—Etoposide—peripheral nervous system neoplasm	0.042	0.0645	CbGbCtD
Clobetasol propionate—Rosacea—Tretinoin—peripheral nervous system neoplasm	0.00743	0.0214	CcSEcCtD
Clobetasol propionate—Rosacea—Isotretinoin—peripheral nervous system neoplasm	0.00743	0.0214	CcSEcCtD
Clobetasol propionate—Dermatitis perioral—Tretinoin—peripheral nervous system neoplasm	0.00714	0.0206	CcSEcCtD
Clobetasol propionate—Dermatitis perioral—Isotretinoin—peripheral nervous system neoplasm	0.00714	0.0206	CcSEcCtD
Clobetasol propionate—Telangiectasia—Isotretinoin—peripheral nervous system neoplasm	0.00688	0.0198	CcSEcCtD
Clobetasol propionate—Telangiectasia—Tretinoin—peripheral nervous system neoplasm	0.00688	0.0198	CcSEcCtD
Clobetasol propionate—Application site pruritus—Tretinoin—peripheral nervous system neoplasm	0.00664	0.0192	CcSEcCtD
Clobetasol propionate—Application site pruritus—Isotretinoin—peripheral nervous system neoplasm	0.00664	0.0192	CcSEcCtD
Clobetasol propionate—Acneiform eruption—Tretinoin—peripheral nervous system neoplasm	0.00642	0.0185	CcSEcCtD
Clobetasol propionate—Acneiform eruption—Isotretinoin—peripheral nervous system neoplasm	0.00642	0.0185	CcSEcCtD
Clobetasol propionate—Rosacea—Alitretinoin—peripheral nervous system neoplasm	0.00563	0.0162	CcSEcCtD
Clobetasol propionate—Secondary infection—Isotretinoin—peripheral nervous system neoplasm	0.00552	0.0159	CcSEcCtD
Clobetasol propionate—Miliaria—Tretinoin—peripheral nervous system neoplasm	0.00552	0.0159	CcSEcCtD
Clobetasol propionate—Miliaria—Isotretinoin—peripheral nervous system neoplasm	0.00552	0.0159	CcSEcCtD
Clobetasol propionate—Secondary infection—Tretinoin—peripheral nervous system neoplasm	0.00552	0.0159	CcSEcCtD
Clobetasol propionate—Dermatitis perioral—Alitretinoin—peripheral nervous system neoplasm	0.00541	0.0156	CcSEcCtD
Clobetasol propionate—Skin atrophy—Tretinoin—peripheral nervous system neoplasm	0.00537	0.0155	CcSEcCtD
Clobetasol propionate—Skin atrophy—Isotretinoin—peripheral nervous system neoplasm	0.00537	0.0155	CcSEcCtD
Clobetasol propionate—Telangiectasia—Alitretinoin—peripheral nervous system neoplasm	0.00522	0.015	CcSEcCtD
Clobetasol propionate—Skin striae—Tretinoin—peripheral nervous system neoplasm	0.0051	0.0147	CcSEcCtD
Clobetasol propionate—Skin striae—Isotretinoin—peripheral nervous system neoplasm	0.0051	0.0147	CcSEcCtD
Clobetasol propionate—Application site pruritus—Alitretinoin—peripheral nervous system neoplasm	0.00503	0.0145	CcSEcCtD
Clobetasol propionate—Acneiform eruption—Alitretinoin—peripheral nervous system neoplasm	0.00487	0.014	CcSEcCtD
Clobetasol propionate—Dermatitis acneiform—Isotretinoin—peripheral nervous system neoplasm	0.00475	0.0137	CcSEcCtD
Clobetasol propionate—Dermatitis acneiform—Tretinoin—peripheral nervous system neoplasm	0.00475	0.0137	CcSEcCtD
Clobetasol propionate—Allergic contact dermatitis—Isotretinoin—peripheral nervous system neoplasm	0.00464	0.0134	CcSEcCtD
Clobetasol propionate—Allergic contact dermatitis—Tretinoin—peripheral nervous system neoplasm	0.00464	0.0134	CcSEcCtD
Clobetasol propionate—Miliaria—Alitretinoin—peripheral nervous system neoplasm	0.00418	0.0121	CcSEcCtD
Clobetasol propionate—Secondary infection—Alitretinoin—peripheral nervous system neoplasm	0.00418	0.0121	CcSEcCtD
Clobetasol propionate—Skin atrophy—Alitretinoin—peripheral nervous system neoplasm	0.00407	0.0117	CcSEcCtD
Clobetasol propionate—Skin striae—Alitretinoin—peripheral nervous system neoplasm	0.00387	0.0111	CcSEcCtD
Clobetasol propionate—Leukoderma—Tretinoin—peripheral nervous system neoplasm	0.00382	0.011	CcSEcCtD
Clobetasol propionate—Leukoderma—Isotretinoin—peripheral nervous system neoplasm	0.00382	0.011	CcSEcCtD
Clobetasol propionate—Application site pain—Tretinoin—peripheral nervous system neoplasm	0.00369	0.0106	CcSEcCtD
Clobetasol propionate—Application site pain—Isotretinoin—peripheral nervous system neoplasm	0.00369	0.0106	CcSEcCtD
Clobetasol propionate—Dermatitis acneiform—Alitretinoin—peripheral nervous system neoplasm	0.0036	0.0104	CcSEcCtD
Clobetasol propionate—Allergic contact dermatitis—Alitretinoin—peripheral nervous system neoplasm	0.00352	0.0101	CcSEcCtD
Clobetasol propionate—Application site reaction—Isotretinoin—peripheral nervous system neoplasm	0.00346	0.00997	CcSEcCtD
Clobetasol propionate—Application site reaction—Tretinoin—peripheral nervous system neoplasm	0.00346	0.00997	CcSEcCtD
Clobetasol propionate—Leukoderma—Alitretinoin—peripheral nervous system neoplasm	0.00289	0.00834	CcSEcCtD
Clobetasol propionate—Application site pain—Alitretinoin—peripheral nervous system neoplasm	0.00279	0.00806	CcSEcCtD
Clobetasol propionate—Skin hyperpigmentation—Tretinoin—peripheral nervous system neoplasm	0.00273	0.00786	CcSEcCtD
Clobetasol propionate—Skin hyperpigmentation—Isotretinoin—peripheral nervous system neoplasm	0.00273	0.00786	CcSEcCtD
Clobetasol propionate—Application site reaction—Alitretinoin—peripheral nervous system neoplasm	0.00262	0.00756	CcSEcCtD
Clobetasol propionate—Folliculitis—Tretinoin—peripheral nervous system neoplasm	0.00258	0.00744	CcSEcCtD
Clobetasol propionate—Folliculitis—Isotretinoin—peripheral nervous system neoplasm	0.00258	0.00744	CcSEcCtD
Clobetasol propionate—Eruption—Dactinomycin—peripheral nervous system neoplasm	0.00216	0.00621	CcSEcCtD
Clobetasol propionate—Folliculitis—Dactinomycin—peripheral nervous system neoplasm	0.00211	0.00608	CcSEcCtD
Clobetasol propionate—Skin hyperpigmentation—Alitretinoin—peripheral nervous system neoplasm	0.00207	0.00596	CcSEcCtD
Clobetasol propionate—Rash pustular—Isotretinoin—peripheral nervous system neoplasm	0.00203	0.00586	CcSEcCtD
Clobetasol propionate—Rash pustular—Tretinoin—peripheral nervous system neoplasm	0.00203	0.00586	CcSEcCtD
Clobetasol propionate—Tingling sensation—Tretinoin—peripheral nervous system neoplasm	0.00202	0.00582	CcSEcCtD
Clobetasol propionate—Tingling sensation—Isotretinoin—peripheral nervous system neoplasm	0.00202	0.00582	CcSEcCtD
Clobetasol propionate—Stinging—Isotretinoin—peripheral nervous system neoplasm	0.002	0.00577	CcSEcCtD
Clobetasol propionate—Stinging—Tretinoin—peripheral nervous system neoplasm	0.002	0.00577	CcSEcCtD
Clobetasol propionate—Tingling sensation—Melphalan—peripheral nervous system neoplasm	0.00199	0.00574	CcSEcCtD
Clobetasol propionate—Folliculitis—Alitretinoin—peripheral nervous system neoplasm	0.00196	0.00564	CcSEcCtD
Clobetasol propionate—Eye irritation—Tretinoin—peripheral nervous system neoplasm	0.0019	0.00548	CcSEcCtD
Clobetasol propionate—Eye irritation—Isotretinoin—peripheral nervous system neoplasm	0.0019	0.00548	CcSEcCtD
Clobetasol propionate—Tenderness—Tretinoin—peripheral nervous system neoplasm	0.00186	0.00536	CcSEcCtD
Clobetasol propionate—Tenderness—Isotretinoin—peripheral nervous system neoplasm	0.00186	0.00536	CcSEcCtD
Clobetasol propionate—Secondary infection—Epirubicin—peripheral nervous system neoplasm	0.00183	0.00528	CcSEcCtD
Clobetasol propionate—Secondary infection—Doxorubicin—peripheral nervous system neoplasm	0.00169	0.00488	CcSEcCtD
Clobetasol propionate—Dermatitis contact—Isotretinoin—peripheral nervous system neoplasm	0.0016	0.00462	CcSEcCtD
Clobetasol propionate—Dermatitis contact—Tretinoin—peripheral nervous system neoplasm	0.0016	0.00462	CcSEcCtD
Clobetasol propionate—Rash pustular—Alitretinoin—peripheral nervous system neoplasm	0.00154	0.00444	CcSEcCtD
Clobetasol propionate—Tingling sensation—Alitretinoin—peripheral nervous system neoplasm	0.00153	0.00441	CcSEcCtD
Clobetasol propionate—Stinging—Alitretinoin—peripheral nervous system neoplasm	0.00152	0.00437	CcSEcCtD
Clobetasol propionate—Eye irritation—Alitretinoin—peripheral nervous system neoplasm	0.00144	0.00415	CcSEcCtD
Clobetasol propionate—Tenderness—Alitretinoin—peripheral nervous system neoplasm	0.00141	0.00406	CcSEcCtD
Clobetasol propionate—Leukoderma—Epirubicin—peripheral nervous system neoplasm	0.00127	0.00365	CcSEcCtD
Clobetasol propionate—Dermatitis contact—Alitretinoin—peripheral nervous system neoplasm	0.00121	0.0035	CcSEcCtD
Clobetasol propionate—Tenderness—Cisplatin—peripheral nervous system neoplasm	0.0012	0.00346	CcSEcCtD
Clobetasol propionate—Tingling sensation—Etoposide—peripheral nervous system neoplasm	0.00119	0.00344	CcSEcCtD
Clobetasol propionate—Pain in extremity—Isotretinoin—peripheral nervous system neoplasm	0.00118	0.00339	CcSEcCtD
Clobetasol propionate—Pain in extremity—Tretinoin—peripheral nervous system neoplasm	0.00118	0.00339	CcSEcCtD
Clobetasol propionate—Leukoderma—Doxorubicin—peripheral nervous system neoplasm	0.00117	0.00338	CcSEcCtD
Clobetasol propionate—Dry skin—Tretinoin—peripheral nervous system neoplasm	0.00108	0.00311	CcSEcCtD
Clobetasol propionate—Dry skin—Isotretinoin—peripheral nervous system neoplasm	0.00108	0.00311	CcSEcCtD
Clobetasol propionate—Skin hyperpigmentation—Epirubicin—peripheral nervous system neoplasm	0.000904	0.00261	CcSEcCtD
Clobetasol propionate—Pain in extremity—Alitretinoin—peripheral nervous system neoplasm	0.000892	0.00257	CcSEcCtD
Clobetasol propionate—Eruption—Epirubicin—peripheral nervous system neoplasm	0.000874	0.00252	CcSEcCtD
Clobetasol propionate—Pain in extremity—Vincristine—peripheral nervous system neoplasm	0.00086	0.00248	CcSEcCtD
Clobetasol propionate—Folliculitis—Epirubicin—peripheral nervous system neoplasm	0.000856	0.00247	CcSEcCtD
Clobetasol propionate—Psoriasis—Epirubicin—peripheral nervous system neoplasm	0.000856	0.00247	CcSEcCtD
Clobetasol propionate—Skin hyperpigmentation—Doxorubicin—peripheral nervous system neoplasm	0.000837	0.00241	CcSEcCtD
Clobetasol propionate—Dry skin—Alitretinoin—peripheral nervous system neoplasm	0.000818	0.00236	CcSEcCtD
Clobetasol propionate—Hypoaesthesia—Topotecan—peripheral nervous system neoplasm	0.000817	0.00236	CcSEcCtD
Clobetasol propionate—Hypoaesthesia—Tretinoin—peripheral nervous system neoplasm	0.00081	0.00234	CcSEcCtD
Clobetasol propionate—Hypoaesthesia—Isotretinoin—peripheral nervous system neoplasm	0.00081	0.00234	CcSEcCtD
Clobetasol propionate—Eruption—Doxorubicin—peripheral nervous system neoplasm	0.000809	0.00233	CcSEcCtD
Clobetasol propionate—Oedema peripheral—Tretinoin—peripheral nervous system neoplasm	0.000802	0.00231	CcSEcCtD
Clobetasol propionate—Oedema peripheral—Isotretinoin—peripheral nervous system neoplasm	0.000802	0.00231	CcSEcCtD
Clobetasol propionate—Psoriasis—Doxorubicin—peripheral nervous system neoplasm	0.000792	0.00228	CcSEcCtD
Clobetasol propionate—Folliculitis—Doxorubicin—peripheral nervous system neoplasm	0.000792	0.00228	CcSEcCtD
Clobetasol propionate—Connective tissue disorder—Melphalan—peripheral nervous system neoplasm	0.00079	0.00228	CcSEcCtD
Clobetasol propionate—Triamcinolone—BCHE—peripheral nervous system neoplasm	0.000749	0.309	CrCbGaD
Clobetasol propionate—Alopecia—Topotecan—peripheral nervous system neoplasm	0.000726	0.00209	CcSEcCtD
Clobetasol propionate—Alopecia—Tretinoin—peripheral nervous system neoplasm	0.00072	0.00208	CcSEcCtD
Clobetasol propionate—Alopecia—Isotretinoin—peripheral nervous system neoplasm	0.00072	0.00208	CcSEcCtD
Clobetasol propionate—Alopecia—Melphalan—peripheral nervous system neoplasm	0.00071	0.00205	CcSEcCtD
Clobetasol propionate—Erythema—Tretinoin—peripheral nervous system neoplasm	0.000709	0.00204	CcSEcCtD
Clobetasol propionate—Erythema—Isotretinoin—peripheral nervous system neoplasm	0.000709	0.00204	CcSEcCtD
Clobetasol propionate—Rash pustular—Epirubicin—peripheral nervous system neoplasm	0.000674	0.00194	CcSEcCtD
Clobetasol propionate—Glycosuria—Epirubicin—peripheral nervous system neoplasm	0.000664	0.00191	CcSEcCtD
Clobetasol propionate—Stinging—Epirubicin—peripheral nervous system neoplasm	0.000664	0.00191	CcSEcCtD
Clobetasol propionate—Rash pustular—Doxorubicin—peripheral nervous system neoplasm	0.000624	0.0018	CcSEcCtD
Clobetasol propionate—Stinging—Doxorubicin—peripheral nervous system neoplasm	0.000614	0.00177	CcSEcCtD
Clobetasol propionate—Glycosuria—Doxorubicin—peripheral nervous system neoplasm	0.000614	0.00177	CcSEcCtD
Clobetasol propionate—Hypoaesthesia—Alitretinoin—peripheral nervous system neoplasm	0.000614	0.00177	CcSEcCtD
Clobetasol propionate—Oedema peripheral—Alitretinoin—peripheral nervous system neoplasm	0.000608	0.00175	CcSEcCtD
Clobetasol propionate—Unspecified disorder of skin and subcutaneous tissue—Topotecan—peripheral nervous system neoplasm	0.000604	0.00174	CcSEcCtD
Clobetasol propionate—Unspecified disorder of skin and subcutaneous tissue—Tretinoin—peripheral nervous system neoplasm	0.0006	0.00173	CcSEcCtD
Clobetasol propionate—Unspecified disorder of skin and subcutaneous tissue—Isotretinoin—peripheral nervous system neoplasm	0.0006	0.00173	CcSEcCtD
Clobetasol propionate—Hypoaesthesia—Vincristine—peripheral nervous system neoplasm	0.000592	0.00171	CcSEcCtD
Clobetasol propionate—Unspecified disorder of skin and subcutaneous tissue—Melphalan—peripheral nervous system neoplasm	0.000592	0.00171	CcSEcCtD
Clobetasol propionate—Alopecia—Dactinomycin—peripheral nervous system neoplasm	0.000588	0.0017	CcSEcCtD
Clobetasol propionate—Connective tissue disorder—Vincristine—peripheral nervous system neoplasm	0.000585	0.00169	CcSEcCtD
Clobetasol propionate—Erythema—Dactinomycin—peripheral nervous system neoplasm	0.00058	0.00167	CcSEcCtD
Clobetasol propionate—Infection—Topotecan—peripheral nervous system neoplasm	0.00058	0.00167	CcSEcCtD
Clobetasol propionate—Infection—Isotretinoin—peripheral nervous system neoplasm	0.000575	0.00166	CcSEcCtD
Clobetasol propionate—Infection—Tretinoin—peripheral nervous system neoplasm	0.000575	0.00166	CcSEcCtD
Clobetasol propionate—Infection—Melphalan—peripheral nervous system neoplasm	0.000567	0.00164	CcSEcCtD
Clobetasol propionate—Skin disorder—Topotecan—peripheral nervous system neoplasm	0.000567	0.00163	CcSEcCtD
Clobetasol propionate—Skin disorder—Tretinoin—peripheral nervous system neoplasm	0.000562	0.00162	CcSEcCtD
Clobetasol propionate—Skin disorder—Isotretinoin—peripheral nervous system neoplasm	0.000562	0.00162	CcSEcCtD
Clobetasol propionate—Skin disorder—Melphalan—peripheral nervous system neoplasm	0.000555	0.0016	CcSEcCtD
Clobetasol propionate—Alopecia—Alitretinoin—peripheral nervous system neoplasm	0.000546	0.00157	CcSEcCtD
Clobetasol propionate—Erythema—Alitretinoin—peripheral nervous system neoplasm	0.000537	0.00155	CcSEcCtD
Clobetasol propionate—Dermatitis contact—Epirubicin—peripheral nervous system neoplasm	0.000532	0.00153	CcSEcCtD
Clobetasol propionate—Alopecia—Vincristine—peripheral nervous system neoplasm	0.000526	0.00152	CcSEcCtD
Clobetasol propionate—Paraesthesia—Topotecan—peripheral nervous system neoplasm	0.000524	0.00151	CcSEcCtD
Clobetasol propionate—Paraesthesia—Isotretinoin—peripheral nervous system neoplasm	0.00052	0.0015	CcSEcCtD
Clobetasol propionate—Paraesthesia—Tretinoin—peripheral nervous system neoplasm	0.00052	0.0015	CcSEcCtD
Clobetasol propionate—Connective tissue disorder—Cisplatin—peripheral nervous system neoplasm	0.000517	0.00149	CcSEcCtD
Clobetasol propionate—Paraesthesia—Melphalan—peripheral nervous system neoplasm	0.000513	0.00148	CcSEcCtD
Clobetasol propionate—Pain—Topotecan—peripheral nervous system neoplasm	0.000499	0.00144	CcSEcCtD
Clobetasol propionate—Pain—Isotretinoin—peripheral nervous system neoplasm	0.000495	0.00143	CcSEcCtD
Clobetasol propionate—Pain—Tretinoin—peripheral nervous system neoplasm	0.000495	0.00143	CcSEcCtD
Clobetasol propionate—Dermatitis contact—Doxorubicin—peripheral nervous system neoplasm	0.000492	0.00142	CcSEcCtD
Clobetasol propionate—Pain—Melphalan—peripheral nervous system neoplasm	0.000488	0.00141	CcSEcCtD
Clobetasol propionate—Hypoaesthesia—Etoposide—peripheral nervous system neoplasm	0.000479	0.00138	CcSEcCtD
Clobetasol propionate—Infection—Dactinomycin—peripheral nervous system neoplasm	0.00047	0.00135	CcSEcCtD
Clobetasol propionate—Alopecia—Cisplatin—peripheral nervous system neoplasm	0.000465	0.00134	CcSEcCtD
Clobetasol propionate—Erythema—Cisplatin—peripheral nervous system neoplasm	0.000458	0.00132	CcSEcCtD
Clobetasol propionate—Unspecified disorder of skin and subcutaneous tissue—Alitretinoin—peripheral nervous system neoplasm	0.000454	0.00131	CcSEcCtD
Clobetasol propionate—Fluticasone furoate—ABCB1—peripheral nervous system neoplasm	0.000436	0.18	CrCbGaD
Clobetasol propionate—Vascular purpura—Epirubicin—peripheral nervous system neoplasm	0.000436	0.00126	CcSEcCtD
Clobetasol propionate—Infection—Alitretinoin—peripheral nervous system neoplasm	0.000436	0.00126	CcSEcCtD
Clobetasol propionate—Hypersensitivity—Topotecan—peripheral nervous system neoplasm	0.00043	0.00124	CcSEcCtD
Clobetasol propionate—Hypersensitivity—Isotretinoin—peripheral nervous system neoplasm	0.000426	0.00123	CcSEcCtD
Clobetasol propionate—Hypersensitivity—Tretinoin—peripheral nervous system neoplasm	0.000426	0.00123	CcSEcCtD
Clobetasol propionate—Skin disorder—Alitretinoin—peripheral nervous system neoplasm	0.000426	0.00123	CcSEcCtD
Clobetasol propionate—Alopecia—Etoposide—peripheral nervous system neoplasm	0.000426	0.00123	CcSEcCtD
Clobetasol propionate—Hypersensitivity—Melphalan—peripheral nervous system neoplasm	0.000421	0.00121	CcSEcCtD
Clobetasol propionate—Infection—Vincristine—peripheral nervous system neoplasm	0.00042	0.00121	CcSEcCtD
Clobetasol propionate—Pruritus—Topotecan—peripheral nervous system neoplasm	0.000413	0.00119	CcSEcCtD
Clobetasol propionate—Pruritus—Tretinoin—peripheral nervous system neoplasm	0.000409	0.00118	CcSEcCtD
Clobetasol propionate—Pruritus—Isotretinoin—peripheral nervous system neoplasm	0.000409	0.00118	CcSEcCtD
Clobetasol propionate—Purpura—Epirubicin—peripheral nervous system neoplasm	0.000405	0.00117	CcSEcCtD
Clobetasol propionate—Pain—Dactinomycin—peripheral nervous system neoplasm	0.000405	0.00117	CcSEcCtD
Clobetasol propionate—Pruritus—Melphalan—peripheral nervous system neoplasm	0.000404	0.00117	CcSEcCtD
Clobetasol propionate—Vascular purpura—Doxorubicin—peripheral nervous system neoplasm	0.000404	0.00116	CcSEcCtD
Clobetasol propionate—Paraesthesia—Alitretinoin—peripheral nervous system neoplasm	0.000394	0.00114	CcSEcCtD
Clobetasol propionate—Pain in extremity—Epirubicin—peripheral nervous system neoplasm	0.00039	0.00113	CcSEcCtD
Clobetasol propionate—Unspecified disorder of skin and subcutaneous tissue—Cisplatin—peripheral nervous system neoplasm	0.000387	0.00112	CcSEcCtD
Clobetasol propionate—Paraesthesia—Vincristine—peripheral nervous system neoplasm	0.000379	0.00109	CcSEcCtD
Clobetasol propionate—Pain—Alitretinoin—peripheral nervous system neoplasm	0.000375	0.00108	CcSEcCtD
Clobetasol propionate—Purpura—Doxorubicin—peripheral nervous system neoplasm	0.000375	0.00108	CcSEcCtD
Clobetasol propionate—Infection—Cisplatin—peripheral nervous system neoplasm	0.000371	0.00107	CcSEcCtD
Clobetasol propionate—Rash—Topotecan—peripheral nervous system neoplasm	0.000368	0.00106	CcSEcCtD
Clobetasol propionate—Dermatitis—Topotecan—peripheral nervous system neoplasm	0.000367	0.00106	CcSEcCtD
Clobetasol propionate—Headache—Topotecan—peripheral nervous system neoplasm	0.000365	0.00105	CcSEcCtD
Clobetasol propionate—Rash—Tretinoin—peripheral nervous system neoplasm	0.000365	0.00105	CcSEcCtD
Clobetasol propionate—Rash—Isotretinoin—peripheral nervous system neoplasm	0.000365	0.00105	CcSEcCtD
Clobetasol propionate—Dermatitis—Tretinoin—peripheral nervous system neoplasm	0.000365	0.00105	CcSEcCtD
Clobetasol propionate—Dermatitis—Isotretinoin—peripheral nervous system neoplasm	0.000365	0.00105	CcSEcCtD
Clobetasol propionate—Skin disorder—Cisplatin—peripheral nervous system neoplasm	0.000363	0.00105	CcSEcCtD
Clobetasol propionate—Headache—Tretinoin—peripheral nervous system neoplasm	0.000363	0.00105	CcSEcCtD
Clobetasol propionate—Headache—Isotretinoin—peripheral nervous system neoplasm	0.000363	0.00105	CcSEcCtD
Clobetasol propionate—Pain—Vincristine—peripheral nervous system neoplasm	0.000361	0.00104	CcSEcCtD
Clobetasol propionate—Pain in extremity—Doxorubicin—peripheral nervous system neoplasm	0.000361	0.00104	CcSEcCtD
Clobetasol propionate—Rash—Melphalan—peripheral nervous system neoplasm	0.00036	0.00104	CcSEcCtD
Clobetasol propionate—Dermatitis—Melphalan—peripheral nervous system neoplasm	0.00036	0.00104	CcSEcCtD
Clobetasol propionate—Dry skin—Epirubicin—peripheral nervous system neoplasm	0.000358	0.00103	CcSEcCtD
Clobetasol propionate—Unspecified disorder of skin and subcutaneous tissue—Etoposide—peripheral nervous system neoplasm	0.000355	0.00102	CcSEcCtD
Clobetasol propionate—Hypersensitivity—Dactinomycin—peripheral nervous system neoplasm	0.000349	0.001	CcSEcCtD
Clobetasol propionate—Methylprednisolone—ABCB1—peripheral nervous system neoplasm	0.000348	0.143	CrCbGaD
Clobetasol propionate—Infection—Etoposide—peripheral nervous system neoplasm	0.00034	0.000981	CcSEcCtD
Clobetasol propionate—Paraesthesia—Cisplatin—peripheral nervous system neoplasm	0.000336	0.000967	CcSEcCtD
Clobetasol propionate—Skin disorder—Etoposide—peripheral nervous system neoplasm	0.000333	0.000959	CcSEcCtD
Clobetasol propionate—Dry skin—Doxorubicin—peripheral nervous system neoplasm	0.000331	0.000955	CcSEcCtD
Clobetasol propionate—Hypersensitivity—Alitretinoin—peripheral nervous system neoplasm	0.000323	0.000932	CcSEcCtD
Clobetasol propionate—Pain—Cisplatin—peripheral nervous system neoplasm	0.00032	0.000921	CcSEcCtD
Clobetasol propionate—Hypersensitivity—Vincristine—peripheral nervous system neoplasm	0.000311	0.000898	CcSEcCtD
Clobetasol propionate—Pruritus—Alitretinoin—peripheral nervous system neoplasm	0.00031	0.000895	CcSEcCtD
Clobetasol propionate—Paraesthesia—Etoposide—peripheral nervous system neoplasm	0.000307	0.000886	CcSEcCtD
Clobetasol propionate—Hyperglycaemia—Epirubicin—peripheral nervous system neoplasm	0.000304	0.000878	CcSEcCtD
Clobetasol propionate—Rash—Dactinomycin—peripheral nervous system neoplasm	0.000298	0.00086	CcSEcCtD
Clobetasol propionate—Pain—Etoposide—peripheral nervous system neoplasm	0.000293	0.000844	CcSEcCtD
Clobetasol propionate—Hyperglycaemia—Doxorubicin—peripheral nervous system neoplasm	0.000282	0.000812	CcSEcCtD
Clobetasol propionate—Rash—Alitretinoin—peripheral nervous system neoplasm	0.000277	0.000797	CcSEcCtD
Clobetasol propionate—Dermatitis—Alitretinoin—peripheral nervous system neoplasm	0.000276	0.000797	CcSEcCtD
Clobetasol propionate—Hypersensitivity—Cisplatin—peripheral nervous system neoplasm	0.000275	0.000794	CcSEcCtD
Clobetasol propionate—Headache—Alitretinoin—peripheral nervous system neoplasm	0.000275	0.000792	CcSEcCtD
Clobetasol propionate—Hypoaesthesia—Epirubicin—peripheral nervous system neoplasm	0.000269	0.000775	CcSEcCtD
Clobetasol propionate—Rash—Vincristine—peripheral nervous system neoplasm	0.000266	0.000768	CcSEcCtD
Clobetasol propionate—Dermatitis—Vincristine—peripheral nervous system neoplasm	0.000266	0.000768	CcSEcCtD
Clobetasol propionate—Prednisone—ABCB1—peripheral nervous system neoplasm	0.000266	0.11	CrCbGaD
Clobetasol propionate—Oedema peripheral—Epirubicin—peripheral nervous system neoplasm	0.000266	0.000767	CcSEcCtD
Clobetasol propionate—Connective tissue disorder—Epirubicin—peripheral nervous system neoplasm	0.000265	0.000765	CcSEcCtD
Clobetasol propionate—Headache—Vincristine—peripheral nervous system neoplasm	0.000265	0.000763	CcSEcCtD
Clobetasol propionate—Hypersensitivity—Etoposide—peripheral nervous system neoplasm	0.000252	0.000727	CcSEcCtD
Clobetasol propionate—Hypoaesthesia—Doxorubicin—peripheral nervous system neoplasm	0.000249	0.000717	CcSEcCtD
Clobetasol propionate—Oedema peripheral—Doxorubicin—peripheral nervous system neoplasm	0.000246	0.00071	CcSEcCtD
Clobetasol propionate—Connective tissue disorder—Doxorubicin—peripheral nervous system neoplasm	0.000246	0.000708	CcSEcCtD
Clobetasol propionate—Prednisolone—ABCB1—peripheral nervous system neoplasm	0.000245	0.101	CrCbGaD
Clobetasol propionate—Pruritus—Etoposide—peripheral nervous system neoplasm	0.000242	0.000698	CcSEcCtD
Clobetasol propionate—Betamethasone—ABCB1—peripheral nervous system neoplasm	0.00024	0.0991	CrCbGaD
Clobetasol propionate—Alopecia—Epirubicin—peripheral nervous system neoplasm	0.000239	0.000688	CcSEcCtD
Clobetasol propionate—Rash—Cisplatin—peripheral nervous system neoplasm	0.000236	0.000679	CcSEcCtD
Clobetasol propionate—Dermatitis—Cisplatin—peripheral nervous system neoplasm	0.000235	0.000679	CcSEcCtD
Clobetasol propionate—Erythema—Epirubicin—peripheral nervous system neoplasm	0.000235	0.000678	CcSEcCtD
Clobetasol propionate—Alopecia—Doxorubicin—peripheral nervous system neoplasm	0.000221	0.000637	CcSEcCtD
Clobetasol propionate—Erythema—Doxorubicin—peripheral nervous system neoplasm	0.000218	0.000627	CcSEcCtD
Clobetasol propionate—Rash—Etoposide—peripheral nervous system neoplasm	0.000216	0.000622	CcSEcCtD
Clobetasol propionate—Dermatitis—Etoposide—peripheral nervous system neoplasm	0.000216	0.000622	CcSEcCtD
Clobetasol propionate—Headache—Etoposide—peripheral nervous system neoplasm	0.000214	0.000618	CcSEcCtD
Clobetasol propionate—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—peripheral nervous system neoplasm	0.000199	0.000573	CcSEcCtD
Clobetasol propionate—Infection—Epirubicin—peripheral nervous system neoplasm	0.000191	0.00055	CcSEcCtD
Clobetasol propionate—Skin disorder—Epirubicin—peripheral nervous system neoplasm	0.000186	0.000537	CcSEcCtD
Clobetasol propionate—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—peripheral nervous system neoplasm	0.000184	0.00053	CcSEcCtD
Clobetasol propionate—Infection—Doxorubicin—peripheral nervous system neoplasm	0.000176	0.000509	CcSEcCtD
Clobetasol propionate—Skin disorder—Doxorubicin—peripheral nervous system neoplasm	0.000172	0.000497	CcSEcCtD
Clobetasol propionate—Paraesthesia—Epirubicin—peripheral nervous system neoplasm	0.000172	0.000497	CcSEcCtD
Clobetasol propionate—Pain—Epirubicin—peripheral nervous system neoplasm	0.000164	0.000473	CcSEcCtD
Clobetasol propionate—Paraesthesia—Doxorubicin—peripheral nervous system neoplasm	0.000159	0.00046	CcSEcCtD
Clobetasol propionate—Pain—Doxorubicin—peripheral nervous system neoplasm	0.000152	0.000438	CcSEcCtD
Clobetasol propionate—Hypersensitivity—Epirubicin—peripheral nervous system neoplasm	0.000141	0.000408	CcSEcCtD
Clobetasol propionate—Dexamethasone—ABCB1—peripheral nervous system neoplasm	0.00014	0.0576	CrCbGaD
Clobetasol propionate—Pruritus—Epirubicin—peripheral nervous system neoplasm	0.000136	0.000391	CcSEcCtD
Clobetasol propionate—Hypersensitivity—Doxorubicin—peripheral nervous system neoplasm	0.000131	0.000377	CcSEcCtD
Clobetasol propionate—Pruritus—Doxorubicin—peripheral nervous system neoplasm	0.000126	0.000362	CcSEcCtD
Clobetasol propionate—Rash—Epirubicin—peripheral nervous system neoplasm	0.000121	0.000349	CcSEcCtD
Clobetasol propionate—Dermatitis—Epirubicin—peripheral nervous system neoplasm	0.000121	0.000349	CcSEcCtD
Clobetasol propionate—Headache—Epirubicin—peripheral nervous system neoplasm	0.00012	0.000347	CcSEcCtD
Clobetasol propionate—Rash—Doxorubicin—peripheral nervous system neoplasm	0.000112	0.000323	CcSEcCtD
Clobetasol propionate—Dermatitis—Doxorubicin—peripheral nervous system neoplasm	0.000112	0.000323	CcSEcCtD
Clobetasol propionate—Headache—Doxorubicin—peripheral nervous system neoplasm	0.000111	0.000321	CcSEcCtD
